"You can find confined and very limited permissions for sure pharmaceutical organizations to employ that substance for investigation functions and for extremely unique narrowly prescribed healthcare purposes," he spelled out.“Harm reduction is actually a critically crucial and mainstream subject, and we are remaining in the forefront of drug rule